Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 136

1.

Alcohol and cannabis use and mortality in people with schizophrenia and related psychotic disorders.

Koola MM, McMahon RP, Wehring HJ, Liu F, Mackowick KM, Warren KR, Feldman S, Shim JC, Love RC, Kelly DL.

J Psychiatr Res. 2012 Aug;46(8):987-93. doi: 10.1016/j.jpsychires.2012.04.019. Epub 2012 May 16.

PMID:
22595870
[PubMed - indexed for MEDLINE]
Free PMC Article
2.

[Effect of comorbid substance use on neuropsychological performance in subjects with psychotic or mood disorders].

Liraud F, Verdoux H.

Encephale. 2002 Mar-Apr;28(2):160-8. French.

PMID:
11972143
[PubMed - indexed for MEDLINE]
3.

The impact of alcohol and illicit drugs on people with psychosis: the second Australian National Survey of Psychosis.

Moore E, Mancuso SG, Slade T, Galletly C, Castle DJ.

Aust N Z J Psychiatry. 2012 Sep;46(9):864-78. doi: 10.1177/0004867412443900. Epub 2012 Apr 3.

PMID:
22472772
[PubMed - indexed for MEDLINE]
4.

Association of pre-onset cannabis, alcohol, and tobacco use with age at onset of prodrome and age at onset of psychosis in first-episode patients.

Compton MT, Kelley ME, Ramsay CE, Pringle M, Goulding SM, Esterberg ML, Stewart T, Walker EF.

Am J Psychiatry. 2009 Nov;166(11):1251-7. doi: 10.1176/appi.ajp.2009.09030311. Epub 2009 Oct 1.

PMID:
19797432
[PubMed - indexed for MEDLINE]
Free PMC Article
5.

[Cannabis and schizophrenia: demographic and clinical correlates].

Dervaux A, Laqueille X, Bourdel MC, Leborgne MH, Olié JP, Lôo H, Krebs MO.

Encephale. 2003 Jan-Feb;29(1):11-7. French.

PMID:
12640322
[PubMed - indexed for MEDLINE]
6.

Cannabis and schizophrenia: results of a follow-up study.

Caspari D.

Eur Arch Psychiatry Clin Neurosci. 1999;249(1):45-9.

PMID:
10195343
[PubMed - indexed for MEDLINE]
7.

Significant relationship between lifetime alcohol use disorders and suicide attempts in an Australian schizophrenia sample.

McLean D, Gladman B, Mowry B.

Aust N Z J Psychiatry. 2012 Feb;46(2):132-40. doi: 10.1177/0004867411433211.

PMID:
22311529
[PubMed - indexed for MEDLINE]
8.

[Sociodemographic profiles, addictive and mental comorbidity in cannabis users in an outpatient specific setting].

Guillem E, Pelissolo A, Vorspan F, Bouchez-Arbabzadeh S, Lépine JP.

Encephale. 2009 Jun;35(3):226-33. doi: 10.1016/j.encep.2008.03.010. Epub 2008 Aug 19. French.

PMID:
19540408
[PubMed - indexed for MEDLINE]
9.

Benzodiazepine use and abuse among patients with severe mental illness and co-occurring substance use disorders.

Brunette MF, Noordsy DL, Xie H, Drake RE.

Psychiatr Serv. 2003 Oct;54(10):1395-401.

PMID:
14557527
[PubMed - indexed for MEDLINE]
10.

[Motivational interviewing for cannabis users with psychotic disorders].

Bonsack C, Montagrin Y, Favrod J, Gibellini S, Conus P.

Encephale. 2007 Oct;33(5):819-26. French.

PMID:
18357854
[PubMed - indexed for MEDLINE]
11.

Lifetime positive symptoms in patients with schizophrenia and cannabis abuse are partially explained by co-morbid addiction.

Dubertret C, Bidard I, Adès J, Gorwood P.

Schizophr Res. 2006 Sep;86(1-3):284-90. Epub 2006 Jun 27.

PMID:
16806837
[PubMed - indexed for MEDLINE]
12.

Cannabis use and the course of schizophrenia: 10-year follow-up after first hospitalization.

Foti DJ, Kotov R, Guey LT, Bromet EJ.

Am J Psychiatry. 2010 Aug;167(8):987-93. doi: 10.1176/appi.ajp.2010.09020189. Epub 2010 May 17.

PMID:
20478874
[PubMed - indexed for MEDLINE]
Free PMC Article
13.

[Cannabis cessation interventions offered to young French users: predictors of follow-up].

Abdoul H, Le Faou AL, Bouchez J, Touzeau D, Lagrue G.

Encephale. 2012 Apr;38(2):141-8. doi: 10.1016/j.encep.2011.04.007. Epub 2011 Aug 31. French.

PMID:
22516272
[PubMed - indexed for MEDLINE]
14.

Cannabis-induced psychosis and subsequent schizophrenia-spectrum disorders: follow-up study of 535 incident cases.

Arendt M, Rosenberg R, Foldager L, Perto G, Munk-Jørgensen P.

Br J Psychiatry. 2005 Dec;187:510-5.

PMID:
16319402
[PubMed - indexed for MEDLINE]
Free Article
15.

Cannabis use in patients with a first psychotic episode and subjects at ultra high risk of psychosis: impact on psychotic- and pre-psychotic symptoms.

Machielsen M, van der Sluis S, de Haan L.

Aust N Z J Psychiatry. 2010 Aug;44(8):721-8. doi: 10.3109/00048671003689710.

PMID:
20636193
[PubMed - indexed for MEDLINE]
16.

Cannabis, schizophrenia and other non-affective psychoses: 35 years of follow-up of a population-based cohort.

Manrique-Garcia E, Zammit S, Dalman C, Hemmingsson T, Andreasson S, Allebeck P.

Psychol Med. 2012 Jun;42(6):1321-8. doi: 10.1017/S0033291711002078. Epub 2011 Oct 17.

PMID:
21999906
[PubMed - indexed for MEDLINE]
17.

Perceived risk associated with tobacco, alcohol and cannabis use among people with and without psychotic disorders.

Thornton LK, Baker AL, Johnson MP, Lewin T.

Addict Behav. 2013 Jun;38(6):2246-51. doi: 10.1016/j.addbeh.2013.02.003. Epub 2013 Feb 18.

PMID:
23507458
[PubMed - indexed for MEDLINE]
18.

Cannabis, vulnerability, and the onset of schizophrenia: an epidemiological perspective.

Hambrecht M, Häfner H.

Aust N Z J Psychiatry. 2000 Jun;34(3):468-75.

PMID:
10881971
[PubMed - indexed for MEDLINE]
19.

Prospective study of cannabis use in adolescents at clinical high risk for psychosis: impact on conversion to psychosis and functional outcome.

Auther AM, McLaughlin D, Carrión RE, Nagachandran P, Correll CU, Cornblatt BA.

Psychol Med. 2012 Dec;42(12):2485-97. doi: 10.1017/S0033291712000803. Epub 2012 Apr 30.

PMID:
22716931
[PubMed - indexed for MEDLINE]
Free PMC Article
20.

A controlled family study of cannabis users with and without psychosis.

Proal AC, Fleming J, Galvez-Buccollini JA, Delisi LE.

Schizophr Res. 2014 Jan;152(1):283-8. doi: 10.1016/j.schres.2013.11.014. Epub 2013 Dec 2.

PMID:
24309013
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk